Philip F. Halloran

Transplantation · 2003–2018

A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Transplantation — 25 citations into it
• Surgery — 19 citations into it
• Immunology — 12 citations into it
• Public Health, Environmental and Occupational Health — 9 citations into it

Whom Philip F. Halloran trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Shimon Sakaguchi
2. M. Schnitzler
3. Ronald H. Schwartz
4. A. Macdonald

Papers from Philip F. Halloran's perspective

Ordered by how strongly the researchers Philip F. Halloran trusts endorse each paper. Same corpus, a different order for every researcher.

1. The natural history of chronic allograft nephropathy. (Journal of Urology)
2. Reduced exposure to calcineurin inhibitors in renal transplantation. (New England Journal of Medicine)
3. Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) (American Journal of Transplantation)
4. PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE… (Transplantation)
5. A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) (American Journal of Transplantation)
6. Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions (American Journal of Transplantation)
7. Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (American Journal of Transplantation)
8. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology (American Journal of Transplantation)
9. Belatacept and Long-Term Outcomes in Kidney Transplantation. (New England Journal of Medicine)
10. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. (The Journal of Heart and Lung Transplantation)

Their papers

• The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials (2018) — 959 citations
• Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence (2012) — 1,035 citations
• Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (2010) — 776 citations
• Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions (2008) — 782 citations
• Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) (2007) — 1,114 citations
• Immunosuppressive drugs for kidney transplantation. (2004) — 825 citations
• Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection (2003) — 1,063 citations